GLENMARK LIFE SCIENCES
Back to Cashflow Statement
|
GLENMARK LIFE SCIENCES Last 5 Year Cash Flow from Operating Activities History
[Standalone]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Cash Flow from Operating Activities | ₹414 Cr | ₹306 Cr | ₹598 Cr | ₹388 Cr | ₹195 Cr |
What is the latest Cash Flow from Operating Activities ratio of GLENMARK LIFE SCIENCES ?
Year | Cash Flow from Operating Activities |
---|---|
Mar2024 | ₹414 Cr |
Mar2023 | ₹306 Cr |
Mar2022 | ₹598 Cr |
Mar2021 | ₹388 Cr |
Mar2020 | ₹195 Cr |
How is Cash Flow from Operating Activities of GLENMARK LIFE SCIENCES Trending?
Years | Cash Flow from Operating Activities | % Change | |
---|---|---|---|
Mar2024 | ₹414 Cr | 35.13 | |
Mar2023 | ₹306 Cr | -48.79 | |
Mar2022 | ₹598 Cr | 53.97 | |
Mar2021 | ₹388 Cr | 99.03 | |
Mar2020 | ₹195 Cr | - |
Compare Cash Flow from Operating Activities of peers of GLENMARK LIFE SCIENCES
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
GLENMARK LIFE SCIENCES | ₹15,144.7 Cr | 7.1% | 20.1% | 38.9% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹418,084.0 Cr | -0% | -4.6% | 18.9% | Stock Analytics | |
DIVIS LABORATORIES | ₹162,384.0 Cr | 8.8% | 5.1% | 64.4% | Stock Analytics | |
CIPLA | ₹118,853.0 Cr | 2.4% | -1.1% | 0.8% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹103,143.0 Cr | 2.6% | -9.9% | -0.4% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹101,459.0 Cr | 3.6% | -0.1% | 22.7% | Stock Analytics |
GLENMARK LIFE SCIENCES Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
GLENMARK LIFE SCIENCES | 7.1% |
20.1% |
38.9% |
SENSEX | 0.7% |
-0.1% |
8.8% |
You may also like the below Video Courses